Summary
- Current Price
- As of today, KLRA price is $17.32, up +2.24% on
- Current Price All-Time High
- KLRA price is currently -38.65% below its historical high of $28.23 set on
- Market Cap
- KLRA current market cap is $2B
- Revenue
- KLRA current annual revenue is $0.00, unchanged year-over-year
- Next Earnings
- The next earnings release for KLRA is on
Profile
| Metric | Value |
|---|---|
| Full Name | Kailera Therapeutics, Inc. |
| Ticker | NASDAQ: KLRA |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | kailera.com |
| Employees | 145 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| Price | $17.32 | |
| Price, 1D Change | +2.24% | |
| $2B | ||
| - | ||
| - | ||
| 1.23 | ||
| $0 | ||
| Revenue, 1Y Change | 0.00% | |
| -$1.76 | ||
| EPS, 1Y Change | +32.20% |
Chart
SUGGESTED SERIES
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | N/A | |
| Last Ann. Earnings | N/A | |
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | N/A | N/A |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| -$1.76 | ||
| EPS Estimate | N/A | -$3.97 |
| EPS Est. Change | N/A | -125.60% |
| $0.00 | ||
| Revenue Estimate | N/A | - |
| Revenue Est. Change | N/A | - |
| Current Price | $17.32 | |
| Price Target | - | $42.00 |
| Price Tgt. Change | - | +142.49% |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| - | -$2.60 | - | |
| - | -$1.76 | - | |
| -$3.97 | N/A | -125.60% | |
| -$4.10 | N/A | -132.74% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| - | $0.00 | - | |
| - | $0.00 | - | |
| - | N/A | - | |
| - | N/A | - |
🔒 Log In To Unlock Full Data
Performance
Technicals
| Metric | Date | Value |
|---|---|---|
| Current Price | $17.32 | |
| $21.08 | ||
| $20.07 | ||
| - | ||
| $19.95 | ||
| -$1.04 | ||
| 1.23 | ||
| $1.36 | ||
| 39.18 | ||
| 38.25% |
Dividends
| Metric | Date | Value |
|---|---|---|
| N/A | - | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| $0.00 | ||
| -$1.76 | ||
| -$310.00K | ||
| - | ||
| -$158.34M | ||
| - | ||
| -$148.96M | ||
| - | ||
| -$158.03M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| 0.02 | ||
| 12.01 | ||
| 12.01 | ||
| - | ||
| - | ||
| 23.21 |
Valuations
| Metric | Date | Value |
|---|---|---|
| - | ||
| - | ||
| -5.19 | ||
| -32.26 | ||
| N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| -$356.46M | ||
| $546.06M | ||
| $692.41M | ||
| $557.54M | ||
| $56.51M | ||
| $46.41M | ||
| $10.75M | ||
| $1.04M | ||
| $7.53M |
Expenses
| Metric | Date | Value |
|---|---|---|
| $148.96M | ||
| $158.03M | ||
| $310.00K | ||
| $49.23M | ||
| $310.00K | ||
| $0.00 | ||
| $0.00 |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| -$120.21M | ||
| -$492.60M | ||
| $598.66M | ||
| $2.09M | ||
| -$122.30M |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| Leerink Partners | ||
| JP Morgan | ||
| Jefferies | ||
| Evercore ISI Group |
Analyst sentiment
Institutional ownership
Screeners with KLRA
FAQ
- What is the ticker symbol for Kailera Therapeutics, Inc.?
- The ticker symbol for Kailera Therapeutics, Inc. is NASDAQ:KLRA
- Does Kailera Therapeutics, Inc. pay dividends?
- No, Kailera Therapeutics, Inc. does not pay dividends
- What sector is Kailera Therapeutics, Inc. in?
- Kailera Therapeutics, Inc. is in the Healthcare sector
- What industry is Kailera Therapeutics, Inc. in?
- Kailera Therapeutics, Inc. is in the Biotechnology industry
- What country is Kailera Therapeutics, Inc. based in?
- Kailera Therapeutics, Inc. is headquartered in United States
- When did Kailera Therapeutics, Inc. go public?
- Kailera Therapeutics, Inc. initial public offering (IPO) was on April 17, 2026
- Is Kailera Therapeutics, Inc. in the S&P 500?
- No, Kailera Therapeutics, Inc. is not included in the S&P 500 index
- Is Kailera Therapeutics, Inc. in the NASDAQ 100?
- No, Kailera Therapeutics, Inc. is not included in the NASDAQ 100 index
- Is Kailera Therapeutics, Inc. in the Dow Jones?
- No, Kailera Therapeutics, Inc. is not included in the Dow Jones index
- When does Kailera Therapeutics, Inc. report earnings?
- The next expected earnings date for Kailera Therapeutics, Inc. is August 7, 2026
Data Sources & References
- KLRA Official Website www.kailera.com
- KLRA Profile on Yahoo Finance finance.yahoo.com/quote/KLRA
- KLRA Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/klra